Efficacy and safety of domestic dasatinib as second-line treatment for chronic myeloid leukemia patients in the chronic phase

Yilin CHEN; Long WANG; Guolin YAN; Zhuangzhi YANG; Zhiping HUANG; Youshan ZHANG; Zhe ZHAO; Chucheng WAN; Ying BAO; Hang XIANG; Hua YIN; Lifeng CHEN; Yingyuan XIONG; Li MENG; Weiming LI.
Chinese Journal of Hematology ; (12): 98-104, 2019.
Artículo en Zh | WPRIM | ID: wpr-810461

Documentos relacionados

  1. [Efficacy and safety of domestic dasatinib as second-line treatment for chronic myeloid leukemia patients in the chronic phase].
  2. Efficacy and safety of domestic dasatinib as second-line treatment for chronic myeloid leukemia patients in the chronic phase